Literature DB >> 27368411

Invariant natural killer T cells: front line fighters in the war against pathogenic microbes.

Catherine M Crosby1, Mitchell Kronenberg2,3.   

Abstract

Invariant natural killer T (iNKT) cells constitute a unique subset of innate-like T cells that have been shown to have crucial roles in a variety of immune responses. iNKT cells are characterized by their expression of both NK cell markers and an invariant T cell receptor (TCR) α chain, which recognizes glycolipids presented by the MHC class I-like molecule CD1d. Despite having a limited antigen repertoire, the iNKT cell response can be very complex, and participate in both protective and harmful immune responses. The protective role of these cells against a variety of pathogens has been particularly well documented. Through the use of these pathogen models, our knowledge of the breadth of the iNKT cell response has been expanded. Specific iNKT cell antigens have been isolated from several different bacteria, from which iNKT cells are critical for protection in mouse models. These responses can be generated by direct, CD1d-mediated activation, or indirect, cytokine-mediated activation, or a combination of the two. This can lead to secretion of a variety of different Th1, Th2, or Th17 cytokines, which differentially impact the downstream immune response against these pathogens. This critical role is emphasized by the conservation of these cells between mice and humans, warranting further investigation into how iNKT cells participate in protective immune responses, with the ultimate goal of harnessing their potential for treatment.

Entities:  

Keywords:  Bacterial infections; CD1d; Innate-like lymphocytes; iNKT

Mesh:

Substances:

Year:  2016        PMID: 27368411      PMCID: PMC5065929          DOI: 10.1007/s00251-016-0933-y

Source DB:  PubMed          Journal:  Immunogenetics        ISSN: 0093-7711            Impact factor:   2.846


  98 in total

1.  Distinct NKT cell subsets are induced by different Chlamydia species leading to differential adaptive immunity and host resistance to the infections.

Authors:  Antony George Joyee; Hongyu Qiu; Shuhe Wang; Yijun Fan; Laura Bilenki; Xi Yang
Journal:  J Immunol       Date:  2007-01-15       Impact factor: 5.422

2.  Cutting edge: the mechanism of invariant NKT cell responses to viral danger signals.

Authors:  Aaron J Tyznik; Emmanuel Tupin; Niranjana A Nagarajan; Min J Her; Chris A Benedict; Mitchell Kronenberg
Journal:  J Immunol       Date:  2008-10-01       Impact factor: 5.422

Review 3.  Role of NKT cells in autoimmune liver disease.

Authors:  Tania Santodomingo-Garzon; Mark G Swain
Journal:  Autoimmun Rev       Date:  2011-06-28       Impact factor: 9.754

4.  A molecular basis for NKT cell recognition of CD1d-self-antigen.

Authors:  Thierry Mallevaey; Andrew J Clarke; James P Scott-Browne; Mary H Young; Laila C Roisman; Daniel G Pellicci; Onisha Patel; Julian P Vivian; Jennifer L Matsuda; James McCluskey; Dale I Godfrey; Philippa Marrack; Jamie Rossjohn; Laurent Gapin
Journal:  Immunity       Date:  2011-03-03       Impact factor: 31.745

5.  An intravascular immune response to Borrelia burgdorferi involves Kupffer cells and iNKT cells.

Authors:  Woo-Yong Lee; Tara J Moriarty; Connie H Y Wong; Hong Zhou; Robert M Strieter; Nico van Rooijen; George Chaconas; Paul Kubes
Journal:  Nat Immunol       Date:  2010-03-14       Impact factor: 25.606

6.  The role of CD1d-restricted NK T lymphocytes in the immune response to oral infection with Salmonella typhimurium.

Authors:  Emma Berntman; Julia Rolf; Cecilia Johansson; Per Anderson; Susanna L Cardell
Journal:  Eur J Immunol       Date:  2005-07       Impact factor: 5.532

7.  Mycobacterial phosphatidylinositol mannoside is a natural antigen for CD1d-restricted T cells.

Authors:  Karsten Fischer; Emmanuel Scotet; Marcus Niemeyer; Heidrun Koebernick; Jens Zerrahn; Sophie Maillet; Robert Hurwitz; Mischo Kursar; Marc Bonneville; Stefan H E Kaufmann; Ulrich E Schaible
Journal:  Proc Natl Acad Sci U S A       Date:  2004-07-08       Impact factor: 11.205

8.  Inescapable need for neutrophils as mediators of cellular innate immunity to acute Pseudomonas aeruginosa pneumonia.

Authors:  Andrew Y Koh; Gregory P Priebe; Christopher Ray; Nico Van Rooijen; Gerald B Pier
Journal:  Infect Immun       Date:  2009-10-05       Impact factor: 3.441

9.  Helicobacter pylori cholesteryl α-glucosides contribute to its pathogenicity and immune response by natural killer T cells.

Authors:  Yuki Ito; Jose Luis Vela; Fumiko Matsumura; Hitomi Hoshino; Aaron Tyznik; Heeseob Lee; Enrico Girardi; Dirk M Zajonc; Robert Liddington; Motohiro Kobayashi; Xingfeng Bao; Jeanna Bugaytsova; Thomas Borén; Rongsheng Jin; Yinong Zong; Peter H Seeberger; Jun Nakayama; Mitchell Kronenberg; Minoru Fukuda
Journal:  PLoS One       Date:  2013-12-02       Impact factor: 3.240

10.  Analysis of T cell antigen receptor (TCR) expression by human peripheral blood CD4-8- alpha/beta T cells demonstrates preferential use of several V beta genes and an invariant TCR alpha chain.

Authors:  S Porcelli; C E Yockey; M B Brenner; S P Balk
Journal:  J Exp Med       Date:  1993-07-01       Impact factor: 14.307

View more
  17 in total

1.  Enhanced oxidative phosphorylation in NKT cells is essential for their survival and function.

Authors:  Ajay Kumar; Kalyani Pyaram; Emily L Yarosz; Hanna Hong; Costas A Lyssiotis; Shailendra Giri; Cheong-Hee Chang
Journal:  Proc Natl Acad Sci U S A       Date:  2019-03-25       Impact factor: 11.205

Review 2.  Sepsis-Induced T Cell Immunoparalysis: The Ins and Outs of Impaired T Cell Immunity.

Authors:  Isaac J Jensen; Frances V Sjaastad; Thomas S Griffith; Vladimir P Badovinac
Journal:  J Immunol       Date:  2018-03-01       Impact factor: 5.422

3.  Differing roles of CD1d2 and CD1d1 proteins in type I natural killer T cell development and function.

Authors:  Srinivasan Sundararaj; Jingjing Zhang; S Harsha Krovi; Romain Bedel; Kathryn D Tuttle; Natacha Veerapen; Gurdyal S Besra; Yogesh Khandokar; T Praveena; Jérôme Le Nours; Jennifer L Matsuda; Jamie Rossjohn; Laurent Gapin
Journal:  Proc Natl Acad Sci U S A       Date:  2018-01-19       Impact factor: 11.205

Review 4.  Donor-unrestricted T cells in the human CD1 system.

Authors:  Shouxiong Huang; D Branch Moody
Journal:  Immunogenetics       Date:  2016-08-09       Impact factor: 2.846

5.  ORAI1 mutations abolishing store-operated Ca2+ entry cause anhidrotic ectodermal dysplasia with immunodeficiency.

Authors:  Jayson Lian; Mario Cuk; Sascha Kahlfuss; Lina Kozhaya; Martin Vaeth; Frédéric Rieux-Laucat; Capucine Picard; Melina J Benson; Antonia Jakovcevic; Karmen Bilic; Iva Martinac; Peter Stathopulos; Imre Kacskovics; Thomas Vraetz; Carsten Speckmann; Stephan Ehl; Thomas Issekutz; Derya Unutmaz; Stefan Feske
Journal:  J Allergy Clin Immunol       Date:  2017-11-16       Impact factor: 10.793

Review 6.  CD1: A Singed Cat of the Three Antigen Presentation Systems.

Authors:  Radoslaw Kaczmarek; Mariola Pasciak; Katarzyna Szymczak-Kulus; Marcin Czerwinski
Journal:  Arch Immunol Ther Exp (Warsz)       Date:  2017-04-06       Impact factor: 4.291

Review 7.  Vaccine Designs Utilizing Invariant NKT-Licensed Antigen-Presenting Cells Provide NKT or T Cell Help for B Cell Responses.

Authors:  Shin-Ichiro Fujii; Satoru Yamasaki; Yusuke Sato; Kanako Shimizu
Journal:  Front Immunol       Date:  2018-06-04       Impact factor: 7.561

8.  TBK-binding protein 1 regulates IL-15-induced autophagy and NKT cell survival.

Authors:  Lele Zhu; Xiaoping Xie; Lingyun Zhang; Hui Wang; Zuliang Jie; Xiaofei Zhou; Jianhong Shi; Shuli Zhao; Boxiang Zhang; Xuhong Cheng; Shao-Cong Sun
Journal:  Nat Commun       Date:  2018-07-18       Impact factor: 14.919

Review 9.  CD1-Restricted T Cells During Persistent Virus Infections: "Sympathy for the Devil".

Authors:  Günther Schönrich; Martin J Raftery
Journal:  Front Immunol       Date:  2018-03-19       Impact factor: 7.561

Review 10.  The Yin and Yang of Invariant Natural Killer T Cells in Tumor Immunity-Suppression of Tumor Immunity in the Intestine.

Authors:  Ying Wang; Susanna L Cardell
Journal:  Front Immunol       Date:  2018-01-10       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.